Researchers are excited about the medication , a novel dual compound showing significant results in clinical trials for body reduction . It acts by modulating both pathways : GLP-1 and GIP, which , when https://jayqgxh755574.canariblogs.com/this-new-prospect-for-weight-management-55690169